REFERENCES
- Ahluwalia JP. Immunotherapy in inflammatory bowel disease. Med Clin North Am. 2012;96:525–544.
- Huang X, Lv B, Jin HF, et al. A meta-analysis of the therapeutic effects of tumor necrosis factor-alpha blockers on ulcerative colitis. Eur J Clin Pharmacol. 2011;67:759–766.
- Bregnbak D, Mortensen C, Bendtsen F. Infliximab and complications after colectomy in patients with ulcerative colitis. J Crohns Colitis. 2012;6:281–286.
- Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. 2007;132:52–65.
- Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006;130:323–333.
- Sandborn WJ, Hanauer SB, Rutgeerts P, et al. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut. 2007;56:1232–1239.
- Subramanian V, Pollok RC, Kang JY, et al. Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators. Br J Surg. 2006;93:793–799.
- El-Hussuna A, Andersen J, Bisgaard T, et al. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease. Scand J Gastroenterol. 2012;47:662–668.
- Samimi R, Flasar MH, Kavic S, et al. Outcome of medical treatment of stricturing and penetrating Crohn's disease: a retrospective study. Inflamm Bowel Dis. 2010;16:1187–1194.
- Syed A, Cross RK, Flasar MH. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in crohn's disease patients. Am J Gastroenterol. 2013 Mar 12.
- Kopylov U, Ben-Horin S, Zmora O, et al. Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis. Inflamm Bowel Dis. 2012;18:2404–2413.
- Appau KA, Fazio VW, Shen B, et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg. 2008;12:1738–1744.
- Canedo J, Lee SH, Pinto R, et al. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates? Colorectal Dis. 2011;13:1294–1298.
- Norgard BM, Nielsen J, Qvist N, et al. Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study. Aliment Pharmacol Ther. 2012;35:1301–1309.
- Urbaniak GC, Plous S. Research Randomizer (version 4.0) [internet]: Social Psychology Network; 2013 [cited 2013 Mar 13]. Available from: www.randomizer.org.
- Verhofstad MH, Lange WP, van der Laak JA, et al. Microscopic analysis of anastomotic healing in the intestine of normal and diabetic rats. Dis Colon Rectum. 2001;44:423–431.
- Lallemand C, Kavrochorianou N, Steenholdt C, et al. Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFalpha antagonists. J Immunol Methods. 2011;28;(373):229–239.
- Ploug T, Andersen K, Hansen K, et al. Influence of adalimumab treatment on anastomotic strength, degree of inflammation, and collagen formation: an experimental study on the small intestine of rabbits. Inflamm Bowel Dis. 2013;19:254–258.
- pro.medicin.dk [internet]: Dansk Lægemiddel Information A/S; [updated 2012 Nov 6; cited 2013 Jul 13]. Available from: www.pro.medicin.dk/Medicin/Praeparater/3237.
- SSI [internet]: Statens Serum Institut; 2013 [updated 2013 May 2; cited 2013 Jul 13]. Available from: www.ssi.dk/ Diagnostik/DiagnostiskHaandbog/400–499/435.aspx.
- Ikeuchi D, Onodera H, Aung T, et al. Correlation of tensile strength with bursting pressure in the evaluation of intestinal anastomosis. Dig Surg. 1999;16:478–485.
- Rossi LF, Ramos RR, Ely JB, et al. Considerations that may influence the result of trials assessing tensile strength in experimental surgery. Acta Cir Bras. 2007;22:499–502.
- Ulmer TF, Stumpf M, Rosch R, et al. Suture-free and mesh reinforced small intestinal anstomoses: a feasibility study in rabbits. J Invest Surg. 2013;26:210–216.
- Thompson SK, Chang EY, Jobe BA. Clinical review: Healing in gastrointestinal anastomoses, part I. Microsurgery. 2006;26:131–136.